It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

Android 16 removes the opt-out clause for edge-to-edge, making full-screen apps a requirement for those targeting the new API ...

Scientists have found a way to achieve negative refraction—where light bends the "wrong" way—using carefully arranged atomic ...

If Razer Cortex is not working, disable and re-enable the feature and run the app with administrative privileges.

Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...

Keep your eye on the ball” is a motto for many athletes—and for astronomers trying to find Earth-threatening space rocks ...

Mistral, the company sometimes considered Europe’s great hope for AI, is releasing several updates to its AI assistant, Le ...

Google is rolling out a number of updates for Gemini 2.0 and making its new 'reasoning' model available for free to users in ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...